Business Relations Table - o4.fyi ()

Anmelden Gast|Guest
Beispiel: brt.php?search=wide&s=wide&p=adjective&o=wideness

Domain-Statistiken für "opzelura.com"

187
Business Relations
183
Eindeutige Domains
20
Gefundene Einträge
BR-Relations: 187
From Domain Role To Domain Path Aktionen
/health/health-conditions/a70988547/what-a-dermatologist-wants-families-to-know-about-atopic-dermatitis/
/2026/01/30/cms-867-hk-8a8-sg-ruxolitinib-phosphate-cream-obtained-china-nda-approval-becoming-the-first-and-only-targeted-drug-for-vitiligo-in-china/
/2026/01/30/cms-867-hk-8a8-sg-ruxolitinib-phosphate-cream-obtained-china-nda-approval-becoming-the-first-and-only-targeted-drug-for-vitiligo-in-china/
/2026/01/30/cms-867-hk-8a8-sg-ruxolitinib-phosphate-cream-obtained-china-nda-approval-becoming-the-first-and-only-targeted-drug-for-vitiligo-in-china/
/smart-living/eczema-treatment-medication-incyte-opzelura-moments-clarity-49333253
/search/label/autoimmune diseases
/
/
/blog/ruxolitinib-a-controversial-new-drug-for-non-segmental-vitiligo
/patient-resources/
/patientresources
/resources/
/cms-867-hk-8a8-sg-ruxolitinib-phosphate-cream-obtained-china-nda-approval-becoming-the-first-and-only-targeted-drug-for-vitiligo-in-china/
/2026/01/30/cms-867-hk-8a8-sg-ruxolitinib-phosphate-cream-obtained-china-nda-approval-becoming-the-first-and-only-targeted-drug-for-vitiligo-in-china/
/press-release/2026-01-30/29018/cms-867-hk-8a8-sg-ruxolitinib-phosphate-cream-obtained-china-nda-approval-becoming-the-first-and-only-targeted-drug-for-vitiligo-in-china
/press-release/2026-01-30/29046/cms-867-hk-8a8-sg-ruxolitinib-phosphate-cream-obtained-china-nda-approval-becoming-the-first-and-only-targeted-drug-for-vitiligo-in-china
/cms-867-hk-8a8-sg-ruxolitinib-phosphate-cream-obtained-china-nda-approval-becoming-the-first-and-only-targeted-drug-for-vitiligo-in-china/
/life-after-opzelura/
/cms-867-hk-8a8-sg-ruxolitinib-phosphate-cream-obtained-china-nda-approval-becoming-the-first-and-only-targeted-drug-for-vitiligo-in-china/
/press-release/2026-01-30/28962/cms-867-hk-8a8-sg-ruxolitinib-phosphate-cream-obtained-china-nda-approval-becoming-the-first-and-only-targeted-drug-for-vitiligo-in-china